Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ACS highlights: design of new antitumor agents based on computer models of tubulin structure

March 23, 1999

New thioureas: synthesis and apoptosis induction

March 23, 1999

SBIR grant to be used by Aurora to identify gene targets, lead compounds relevant to breast cancer

March 23, 1999

Novel acridine-based antitumor agents developed at Italian university

March 23, 1999

Scotia's photodynamic cancer drug receives fast track status from FDA

March 22, 1999

ACS highlights: Agouron and Roche present MMP inhibitor clinical candidate

March 22, 1999

Hungarian research team describes GnRH receptor-targeted antitumor drug conjugates

March 22, 1999

Heterocyclic compounds with antitumor activity developed at Zenyaku Kogyo

March 22, 1999

Angstrom and Diatide to develop new cancer treatments and diagnostic products

March 22, 1999

Japanese market clearance obtained for Casodex 80

March 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...